Clinical Trials
2 trialsNCT05711667 2026-05-05
A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric Patients
Children's Oncology Group
Phase 3 Recruiting
NCT06449586 2025-12-15
CMV-specific T Cell Immunity Test Indicated Prophylaxis of Letermovir After All-HSCT
Ruijin Hospital
Phase 3 Active not recruiting